Skip to main content

Designing porous silicon-based microparticles as carriers for controlled delivery of mitoxantrone dihydrochloride

  • Adi Tzur-Balter (a1), Anna Rubinski (a2) and Ester Segal (a3)

Porous silicon (PSi) microparticles are designed as tunable delivery carriers for the model anticancer drug, mitoxantrone dihydrochloride (MTX). The surface of the native nanostructured PSi particles was chemically modified by grafting dodecyl and undecanoic acid via thermal hydrosilylation with 1-dodecene and undecylenic acid, respectively. Attenuated total reflectance Fourier transform infrared spectroscopy and nitrogen adsorption–desorption measurements were used to characterize the physiochemical properties of the native and chemically modified PSi microparticles. MTX was loaded by physical adsorption to the native and dodecyl-terminated PSi or by covalent attachment to the undecanoic acid-terminated microparticles. Both drug release profile and the Si erosion of the carriers were significantly affected by the surface chemistry of the PSi microparticles and the drug loading method. The MTX release spans over a period of several hours to weeks, as dictated by these parameters. In vitro cytotoxicity studies on human breast carcinoma (MDA-MB-231) cells revealed that the released MTX maintains its cytotoxic functionality, in comparison to the very low toxicity of all PSi microparticles.

Corresponding author
b)Address all correspondence to this author. e-mail:
Hide All
1.Bonanno, L.M. and Segal, E.: Nanostructured porous silicon-polymer-based hybrids: From biosensing to drug delivery. Nanomedicine 6(10), 1755 (2011).
2.Bimbo, L.M., Sarparanta, M., Santos, H.A., Airaksinen, A.J., Makila, E., Laaksonen, T., Peltonen, L., Lehto, V.P., Hirvonen, J., and Salonen, J.: Biocompatibility of thermally hydrocarbonized porous silicon nanoparticles and their biodistribution in rats. ACS Nano 4(6), 3023 (2010).
3.Salonen, J., Kaukonen, A.M., Hirvonen, J., and Lehto, V.P.: Mesoporous silicon in drug delivery applications. J. Pharm. Sci. 97(2), 632 (2008).
4.Kinnari, P., Makila, E., Heikkila, T., Salonen, J., Hirvonen, J., and Santos, H.A.: Comparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazole. Int. J. Pharm. 414(1–2), 148 (2011).
5.Li, X., John, J.S., Coffer, J.L., Chen, Y., Pinizzotto, R.F., Newey, J., Reeves, C., and Canham, L.T.: Porosified silicon wafer structures impregnated with platinum anti-tumor compounds: Fabrication, characterization, and diffusion studies. Biomed. Microdevices 2, 265 (2000).
6.Park, J.H., Gu, L., von Maltzahn, G., Ruoslahti, E., Bhatia, S.N., and Sailor, M.J.: Biodegradable luminescent porous silicon nanoparticles for in vivo applications. Nat. Mater. 8(4), 331 (2009).
7.Perelman, L.A., Pacholski, C., Li, Y.Y., VanNieuwenhze, M.S., and Sailor, M.J.: pH-triggered release of vancomycin from protein-capped porous silicon films. Nanomedicine (Lond) 3(1), 31 (2008).
8.Salonen, J., Laitinen, L., Kaukonen, A.M., Tuura, J., Bjorkqvist, M., Heikkila, T., Vaha-Heikkila, K., Hirvonen, J. and Lehto, V.P.: Mesoporous silicon microparticles for oral drug delivery: Loading and release of five model drugs. J. Controlled Release 108(2–3), 362 (2005).
9.Santos, H.A., Salonen, J., Bimbo, L.M., Lehto, V.P., Peltonen, L., and Hirvonen, J.: Mesoporous materials as controlled drug delivery formulations. J. Drug Delivery Sci. Technol. 21(2), 139 (2011).
10.Canham, L.T.: Bioactive silicon structure fabrication through nanoetching techniques. Adv. Mater. 7(12), 1033 (1995).
11.McInnes, J.P.S. and Voelcker, N.H.: Silicon-polymer hybrid materials for drug delivery. Future Med. Chem. 1, 1051 (2009).
12.Artzi, N., Oliva, N., Puron, C., Shitreet, S., Artzi, S., Bon Ramos, A., Groothuis, A., Sahagian, G., and Edelman, E.R.: In vivo and in vitro tracking of erosion in biodegradable materials using non-invasive fluorescence imaging. Nat. Mater. 10, 704 (2011).
13.Godin, B., Gu, J.H., Serda, R.E., Bhavane, R., Tasciotti, E., Chiappini, C., Liu, X.W., Tanaka, T., Decuzzi, P., and Ferrari, M.: Tailoring the degradation kinetics of mesoporous silicon structures through PEGylation. J. Biomed. Mater. Res. Part A 94A, 1236 (2010).
14.Canham, L.T., Stewart, M.P., Buriak, J.M., Reeves, C.L., Anderson, M., Squire, E.K., Allcock, P., and Snow, P.A.: Derivatized porous silicon mirrors: Implantable optical components with slow resorbability. Phys. Status Solidi A 182(1), 521 (2000).
15.Anglin, E.J., Cheng, L.Y., Freeman, W.R., and Sailor, M.J.: Porous silicon in drug delivery devices and materials. Adv. Drug Delivery Rev. 60(11), 1266 (2008).
16.Doughty, J.C., Kane, E., Cooke, T.G., and McArdle, C.S.: Mitoxantrone and methotrexate chemotherapy with and without mitomycin C in the regional treatment of locally advanced breast cancer. Breast 11(1), 97 (2002).
17.Hagemeister, F., Cabanillas, F., Coleman, M., Gregory, S.A., and Zinzani, P.L.: The role of mitoxantrone in the treatment of indolent lymphomas. The Oncologist 10(2), 150 (2005).
18.Brunauer, S., Emmett, P.H., and Teller, E.: Adsorption of gases in multimolecular layers. J. Am. Chem. Soc. 60(309), (1938).
19.Gregg, S.J. and Sing, K.S.W.: Adsorption, Surface Area and Porosity (Academic, London, 1982).
20.Segal, E., Perelman, L.A., Cunin, F., Di Renzo, F., Devoisselle, J.M., Li, Y.Y., and Sailor, M.J.: Confinement of thermoresponsive hydrogels in nanostructured porous silicon dioxide templates. Adv. Funct. Mater. 17(7), 1153 (2007).
21.Santos, H.A., Riikonen, J., Salonen, J., Makila, E., Heikkila, T., Laaksonen, T., Peltonen, L., Lehto, V.P., and Hirvonen, J.: In vitro cytotoxicity of porous silicon microparticles: Effect of the particle concentration, surface chemistry and size. Acta Biomater. 6(7), 2721 (2010).
22.Salonen, J. and Lehto, V.P.: Fabrication and chemical surface modification of mesoporous silicon for biomedical applications. Chem. Eng. J. 137, 162 (2008).
23.Bimbo, L.M., Mäkiläb, E., Laaksonen, T., Lehto, V-P., Salonen, J., Hirvonen, J., and Santos, H.A.: Drug permeation across intestinal epithelial cells using porous silicon nanoparticles. Biomaterials 32(10), 2625 (2011).
24.Chiappini, C., Tasciotti, E., Fakhoury, J.R., Fine, D., Pullan, L., Wang, Y-C., Fu, L., Liu, X., and Ferrari, M.: Tailored porous silicon microparticles: Fabrication and properties. ChemPhysChem 11(5), 1029 (2010).
25.Alvarez, S.D., Derfus, A.M., Schwartz, M.P., Bhatia, S.N., and Sailor, M.J.: The compatibility of hepatocytes with chemically modified porous silicon with reference to in vitro biosensors. Biomaterials 30(1), 26 (2009).
26.Schwartz, M.P., Cunin, F., Cheung, R.W., and Sailor, M.J.: Chemical modification of silicon surfaces for biological applications. Phys. Status Solidi A 202(8), 1380 (2005).
27.Jarvis, K.L., Barnes, T.J., Badalyan, A., Pendleton, P., and Prestidge, C.A.: Impact of thermal oxidation on the adsorptive properties and structure of porous silicon particles. J. Phys. Chem. C, 112, 9717 (2008).
28.Anglin, E.J., Schwartz, M.P., Ng, V.P., Perelman, L.A., and Sailor, M.J.: Engineering the chemistry and nanostructure of porous silicon Fabry-Pérot films for loading and release of a steroid. Langmuir 20(25), 11264 (2004).
29.Wu, E.C., Park, J.H., Park, J., Segal, E., Cunin, F., and Sailor, M.J.: Oxidation-triggered release of fluorescent molecules or drugs from mesoporous Si microparticles. ACS Nano 2(11), 2401 (2008).
30.Kovalainen, M., Mönkäre, J., Mäkilä, E., Salonen, J., Lehto, V.P., Herzig, K.H., and Järvinen, H.: Mesoporous silicon (PSi) for sustained peptide delivery: Effect of PSi microparticle surface chemistry on peptide YY3-36 release. Pharm. Res. 29, 837 (2012).
31.Kovalainen, M., Mönkäre, J., Mäkilä, E., Salonen, J., Lehto, V.P., Herzig, K.H., and Järvinen, H.: Mesoporous silicon (PSi) for sustained peptide delivery: Effect of PSi microparticle surface chemistry on peptide YY3-36 release. Pharm. Res. 29, 837 (2012).
32.Wu, E.C., Andrew, J.S., Cheng, L.Y., Freeman, W.R., Pearson, L., and Sailor, M.J.: Real-time monitoring of sustained drug release using the optical properties of porous silicon photonic crystal particles. Biomaterials 32(7), 1957 (2011).
33.Godin, B., Gu, J.H., Serda, R.E., Bhavane, R., Tasciotti, E., Chiappini, C., Liu, X.W., Tanaka, T., Decuzzi, P., and Ferrari, M.: Tailoring the degradation kinetics of mesoporous silicon structures through PEGylation. J. Biomed. Mater. Res. Part A 94A(4), 1236 (2010).
34.Wise, D.L.: Handbook of Pharmaceutical Controlled Release Technology, 1st ed. (Marcel Dekker Inc., New York, 2000).
35.Kilian, K.A., Booking, T., Gaus, K., Gal, M., and Gooding, J.J.: Si-C linked oligo(ethylene glycol) layers in silicon-based photonic crystals: Optimization for implantable optical materials. Biomaterials 28(20), 3055 (2007).
36.O’Brien, J. and Pognan, F.: Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Toxicology 164(1–3), 132 (2001).
37.Cheng, L., Anglin, E., Cunin, F., Kim, D., Sailor, M.J., Falkenstein, I., Tammewar, A., and Freeman, W.R.: Intravitreal properties of porous silicon photonic crystals: A potential self-reporting intraocular drug-delivery vehicle. Br. J. Ophthalmol. 92(5), 705 (2008).
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Journal of Materials Research
  • ISSN: 0884-2914
  • EISSN: 2044-5326
  • URL: /core/journals/journal-of-materials-research
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
Type Description Title
Supplementary materials

Tzur-Balter Supplementary Material

 Word (51 KB)
51 KB


Full text views

Total number of HTML views: 2
Total number of PDF views: 21 *
Loading metrics...

Abstract views

Total abstract views: 237 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 19th March 2018. This data will be updated every 24 hours.